Vice President

Safety and value driving Phase IV growth at CROs; EVP

Safety and value driving Phase IV growth at CROs; EVP

By Gareth Macdonald

Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence.

CytRx bolstering its manufacturing expertise and KV preparing its management as it strives to resume distribution – People on the move

CytRx bolstering its manufacturing expertise and KV preparing its management as it strives to resume distribution – People on the move

By Nick Taylor

in-PharmaTechnologist presents its latest round up movements in the pharma sector, including CytRx bolstering its manufacturing expertise and KV preparing its management as it strives to resume distribution.

Quintiles inks pharma deals

Quintiles inks pharma deals

By Nick Taylor

Quintiles is continuing to build alliances with large pharmas, inking deals to perform “the majority” of AstraZeneca’s (AZ) clinical pharmacology work and develop six oncology products in Eisai’s pipeline.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All